undamentalytics Newsletter

Adapthealth vs Astrana Health

Adapthealth and Astrana Health are similar in size: $3.24bn and $3.18bn of revenue in their latest fiscal years. Astrana Health grew faster (56.4% against -0.5%). Astrana Health kept more of each dollar of sales as profit: a net margin of 0.7% against -2.2%. Adapthealth carries less debt relative to equity (115.2% against 135.0%).

Latest fiscal yearAdapthealthAHCO, 2025Astrana HealthASTH, 2025
Revenue $3.24bn $3.18bn
Revenue growth -0.5% 56.4%
Net income −$70.8m $22.5m
Operating margin 2.8% 2.5%
Net margin -2.2% 0.7%
Return on equity -4.6% 3.0%
Free cash flow $219m $104m
Cash $106m $429m
Total debt $1.75bn $1.05bn
Debt to equity 115.2% 135.0%
Dividend per share — —
Dividend yield — 0.1%
Share buybacks $0 $25.6m
Employees 10,900 3,000
Market value $806m $1.80bn
Price vs our value range — Below our value range
Moat score 25 (Weak) 36 (Weak)
Insider trades, 12 months 16 buys, 3 sales 0 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.